BETAHISTINE-ZP betahistine dihydrochloride 8mg tablets blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

betahistine dihydrochloride, Quantity: 8 mg

Disponible des:

Medis Pharma Pty Ltd

Designació comuna internacional (DCI):

betahistine dihydrochloride

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: stearic acid; crospovidone; colloidal anhydrous silica; povidone; lactose monohydrate; microcrystalline cellulose

Vía de administración:

Oral

Unidades en paquete:

100 tablets, 10 tablets, 25 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Meniere?s Syndrome as defined by the following core symptoms: ,- vertigo (with nausea/vomiting) ,- hearing loss (hardness of hearing) ,- tinnitus

Resumen del producto:

Visual Identification: White to almost white, round, flat bevelled edged tablets embossed B8 on one side and scored on the other; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Licence status A

Data d'autorització:

2015-11-10